Heat Biologics (HTBX) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts HTBX Hot Sheet
Join SI Premium – FREE
Heat Biologics (NASDAQ: HTBX) reported Q2 EPS of ($0.62), $0.01 worse than the analyst estimate of ($0.61).
For earnings history and earnings-related data on Heat Biologics (HTBX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Freeport Q3 2026 copper output meets targets; gold sales deferred
- Integra LifeSciences cuts 2026 outlook after Cincinnati flood
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
